Spots Global Cancer Trial Database for Review of Multimodality Management of Anaplastic Thyroid Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Review of Multimodality Management of Anaplastic Thyroid Cancer
Official Title: A Retrospective Review of Multimodality Management of Anaplastic Thyroid Cancer
Study ID: NCT00280852
Conditions
Interventions
Study Description
Brief Summary: To describe the outcome of patients with anaplastic thyroid cancer treated with hyperfractionated radiotherapy and concomitant chemotherapy
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Tom Baker Cancer Centre, Calgary, Alberta, Canada
Contact Details
Name: Harold Lau, MD
Affiliation: Alberta Cancerboard
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
